{"pdfurl": "http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2015/07/14/090224b082ff4913/1_0/Rendered/PDF/Mexico000Influ00and0control0project.pdf", "lang": "English", "historic_topic": "Health, Nutrition and Population,Finance and Financial Sector Development", "volnb": "1", "display_title": [{"display_title": "Mexico - Influenza prevention and\n            control project"}], "repnb": "NCO1902", "docna": {"cdata!": "Mexico - Influenza prevention and control project"}, "repnme": {"cdata!": "Mexico - Influenza prevention and control project"}, "owner": "Health, Nutr & Population - GP (GHNDR)", "publishtoextweb_dt": "2015-07-16T00:00:00Z", "subtopic": "Health Monitoring & Evaluation,Health Systems Development & Reform,Access to Finance,Banks & Banking Reform,Disease Control & Prevention", "docty": "Note on Cancelled Operation", "txturl": "http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2015/07/14/090224b082ff4913/1_0/Rendered/INDEX/Mexico000Influ00and0control0project.txt", "listing_relative_url": "/projects/documents/2011/11/24779278/mexico-influenza-prevention-control-project", "teratopic": "Health, Nutrition and Population,Finance and Financial Sector Development", "new_url": "2015/07/24779278/mexico-influenza-prevention-control-project", "entityids": {"entityid": "090224b082ff4913_1_0"}, "disclosure_type_date": "2015-07-16T00:00:00Z", "disclosure_type": "NA", "docm_id": "090224b082ff4913", "projn": "MX-Influenza Prevention And Control -- P116965", "keywd": {"0": {"cdata!": "advisory services, epidemiologists, risks,\n            borrower, budgetary allocations, people, vaccination,\n            financing, information technology, human immunodeficiency\n            virus, interest, prevention, epidemiological analysis,\n            financial assistance, recession, health care, revenues,\n            death, effects, health, loan, epidemic, information\n            technologies, fee, influenza vaccines, loan amount, basic\n            health, borrowers, corruption, viruses, syndrome, saving,\n            public health, financing facility, bank lending, public\n            credit, influenza pandemics, external finance, knowledge,\n            economic activity, diabetes, acute respiratory syndrome,\n            financial sustainability, technical assistance, diseases,\n            loan funds, viral drugs, febrile illness, patients,\n            influenza viruses, emergency situations, natural disasters,\n            paralysis, eligibility criteria, mobile health units,\n            disasters, social security, emergency response, symptoms,\n            reagents, hiv/aids, influenza activity, social development,\n            peoples, epidemics, mortality, bank financing, finance,\n            malignant neoplasms, immune deficiency, vaccination program,\n            grant, neoplasms, human capital, vaccine production,\n            capital, influenza, pandemics, hiv, surveillance,\n            immunodeficiency, alternative sources of financing, bank,\n            credit, medicine, pharmaceuticals, medical services, health\n            outcomes, medical supplies, expenditures, decision making,\n            acute flaccid paralysis, institutional capacity, cold chain,\n            transaction costs, epidemiological surveillance, health\n            surveillance, avian influenza, vaccines, bank loan, virus,\n            children, security, disease control, disease, clinical\n            trials, clinics, investment, id, influenza preparedness,\n            economic crisis, influenza virus, indigenous peoples,\n            infection, research programs, cooperation, infections, all,\n            revenue, acquired immune deficiency syndrome, investments,\n            technical support, infection rates, external financing,\n            strategy, epidemiology, exchange rate, influenza season,\n            lack of information, medicines, vaccine, remittances,\n            adolescent health, vaccination campaigns, aids, health\n            services, implementation, epidemiological surveillance\n            system, production capacity"}}, "url_friendly_title": "http://documents.worldbank.org/curated/en/2015/07/24779278/mexico-influenza-prevention-control-project", "datestored": "2015-07-14T00:00:00Z", "admreg": "Latin America & Caribbean,Latin America & Caribbean", "geo_region_mdks": {"1": {"geo_region_mdk": "North America!$!North America"}, "0": {"geo_region_mdk": "North America!$!North America"}}, "majdocty": "Project Documents", "lndinstr": {"0": {"cdata!": "Emergency Recovery Loan"}}, "available_in": "English", "disclstat": "Disclosed", "chronical_docm_id": "090224b082ff4913", "prdln": "IBRD/IDA", "majtheme": "Human development", "totvolnb": "1", "geo_regions": {"1": {"geo_region": "North America"}, "0": {"geo_region": "North America"}}, "seccl": "Public", "versiontyp_key": "1309935", "subsc": "Health,Public administration- Health", "count": "Mexico", "sectr": "Public Administration, Law, and Justice,Health and other social services", "disclosure_date": "2015-07-14T00:00:00Z", "url": "http://documents.worldbank.org/curated/en/2015/07/24779278/mexico-influenza-prevention-control-project", "theme": "Other communicable diseases,Health system performance", "versiontyp": "Final", "loan_no": "77610", "abstracts": {"cdata!": "The United Mexican States Influenza\n            Prevention and Control Project's financial management\n            residual risk was considered to be modest, with the only\n            financial management risk rated substantial. The\n            project's procurement risk was considered to be\n            substantial, based mostly on the risk posed by the lack of\n            experience of staff in the Directorate of Operations in\n            carrying out procurement processes in accordance with Bank\n            Guidelines, compounded by the emergency nature of the\n            Project. The Bank and Borrower\u2019s performances were both\n            rated moderately satisfactory. The loan was approved by the\n            Bank\u2019s Board on November 24, 2009 and signed on November 30,\n            2009.  After three extensions of the original February 26,\n            2010 effectiveness deadline, the loan lapsed without\n            becoming effective on February 28, 2011.The Federal\n            Secretariat of Health, as the main implementing agency,\n            carried out the Project within its allocated budget.  When\n            it became clear that it would not be possible to utilize\n            loan resources, the loan was left to lapse."}, "docdt": "2011-11-22T08:56:02Z"}